# US 2026/0061001 A1 · Use of composition containing zinc salt and cyclo-hispro for prevention, alleviation or treatment of respiratory disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0061001 A1
- Document ID: US20260061001A1
- Status: Published application
- Kind: A1
- Application number: 19/107,159
- Filed: 2023-08-30
- Published: 2026-03-05
- Earliest claimed: 2022-08-31
- Assignees: Novmetapharma Co., Ltd.
- Applicants: Novmetapharma Co., Ltd.
- Inventors: Hoe Yune JUNG; Jong Su JEON; Do Hyun LEE; Onyu PARK; Seo Yeong BAEK
- Web page: https://patentgrep.com/patent/US20260061001A1

## CPC

- A23L 33/16: Inorganic salts, minerals or trace elements
- A61K 33/30: Zinc; Compounds thereof
- A23L 33/18: Peptides; Protein hydrolysates
- A61K 38/05: Dipeptides
- A61K 38/12: Cyclic peptides {, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C (A61K38/043 - A61K38/046 take precedence)}
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 11/06: Antiasthmatics
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

New uses of a composition containing a zinc salt and cyclo-hispro (CHP) are disclosed. The composition is suitable and effective for the prevention, alleviation, or treatment of respiratory diseases. And, a method for preventing, alleviating, or treating respiratory diseases by using the composition, wherein the composition includes a specific weight ratio of a zinc salt and cyclo-hispro as active ingredients, thereby exhibiting excellent effects of reducing allergic cytokines and decreasing mucus secretion.

## Claims

### Claim at position 1

-22. (canceled)

### Claim 23

A method for preventing, alleviating, or treating a respiratory disease, comprising administering an effective amount of a composition including: a zinc salt including a zinc cation and an anion; and cyclo-hispro or a pharmaceutically acceptable salt thereof, to an individual in need thereof.

### Claim 24 (depends on 23)

The method of claim 23, wherein the weight ratio of the zinc cation:cyclo-hispro or a pharmaceutically acceptable salt thereof is 1:11 to 13.

### Claim 25 (depends on 23)

The method of claim 23, wherein the respiratory disease is one or more diseases selected from the group consisting of respiratory inflammatory lung disease, COPD, sinusitis, allergic rhinitis, lower respiratory tract infections, bronchitis, emphysema, pneumonia, asthma, bronchiectasis, emphysema, sequelae of pulmonary tuberculosis, ARDS, cystic fibrosis, otitis media, and pulmonary fibrosis.

### Claim 26 (depends on 23)

The method of claim 23, wherein the bronchitis is one or more selected from the group consisting of acute bronchitis, chronic bronchitis, allergic bronchitis, infectious bronchitis, traumatic bronchitis, catarrhal bronchitis, purulent bronchitis, obstructive bronchitis, ulcerative bronchitis, and infiltrative bronchitis.

### Claim 27 (depends on 23)

The method of claim 23, wherein the asthma is one or more selected from the group consisting of bronchial asthma, atopic asthma, non-atopic asthma, exercise-induced asthma, aspirin-induced asthma, psychogenic asthma, and alveolar asthma.

### Claim 28 (depends on 23)

The method of claim 23, wherein the composition exhibits the effects of i) reducing allergic cytokines and ii) decreasing mucus secretion.

### Claim 29 (depends on 23)

The method of claim 23, wherein the zinc salt and cyclo-hispro or a pharmaceutically acceptable salt thereof are administered simultaneously, separately, or sequentially.
